An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer

Cancers - Switzerland
doi 10.3390/cancers11060789
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Improving Natural Killer Cell Cancer Immunotherapy

Current Opinion in Organ Transplantation
AllergyImmunologyTransplantation
2015English

Monoclonal Antibody CD133–2 (AC141) Against Hematopoietic Stem Cell Antigen CD133 Shows Crossreactivity With Cytokeratin 18

Journal of Histochemistry and Cytochemistry
AnatomyHistology
2002English

Cd133/Epcam Cancer Stem Cell Markers of Tumour Stage in Colorectal Cancer Cells

Journal of Tissue Science & Engineering
2015English

Evidence for Natural Killer Cell Memory

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2013English

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

Frontiers in Immunology
AllergyImmunology
2015English

Substance P Increases in Vitro Lymphokine-Activated-Killer (LAK) Cell Cytotoxicity Against Fresh Colorectal Cancer Cells

Journal of Surgical Research
Surgery
1992English

Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2016English

Paradoxical Effects of 5-Fu/Folinic Acid on Lymphokine-Activated Killer (LAK) Cell Induction in Patients With Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy